Purchases and Sales Made in Q4 2021 in Biomarin Pharmaceutical Inc (BMRN)
This table provides information about the institutional ownership of Biomarin Pharmaceutical Inc (BMRN) during Q4 2021. The information is specifically focused on institutions that hold shares of BIOMARIN PHARMACEUTICAL INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2022
Q4 2021
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-672K- 45.17% |
$48.2M - $61.4M
|
815K
$54.3M
|
|
|
Feb 14, 2022
Q4 2021
|
Davide Leone & Partners Investment CO Ltd.
London, X0 |
SELL
|
- |
-715KClosed |
$51.3M - $65.4M
|
0
$0
|
|
|
Feb 10, 2022
Q4 2021
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-1.42M- 9.27% |
$102M - $130M
|
13.9M
$926M
|
|
|
Feb 10, 2022
Q4 2021
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-1.64M- 55.82% |
$117M - $150M
|
1.29M
$86.2M
|
|
|
Feb 14, 2022
Q4 2021
|
Capital Research Global Investors
Los Angeles, CA |
SELL
|
- |
-4.97M- 28.19% |
$357M - $455M
|
12.7M
$844M
|